The following files will be available as full release files within this version:
The 'Full" release contains one entry for every concept that has ever been released and new content added for that release. New content added for a specific release may at times include “Inactive” content.
NOTE: The “Delta" release which is intended to contain only those concepts that have been added or changed since the previous release will be considered for a future enhancement at a later date.
This release continues to add additional content from the DPD and includes most of the top 250 moieties and approximately 95% of the DPD content in scope for CCDD.
The table below provides the number of concepts within each CCDD file for this release.
April 2019 CCDD Files | Number of Concepts | Types of Changes in this release |
---|---|---|
Therapeutic Moiety Full Release | 1359 | 44 additions 1 deprecated concept (see TM change below) |
Non-proprietary Therapeutic Product Full Release | 3935 | 123 additions 6 status change from (5 from active to inactive and 1 inactive to active) 1 status change from active to deprecated (see NTP change below) 20 status date changes with no change of status |
Manufactured Product Full Release | 10910 | 367 additions
Formal name changes made:
40 status changes from active to inactive 4 status changes from inactive to active 5 status date changes (no change of status) |
Manufactured Product, Non-proprietary Therapeutic Product, Therapeutic Moiety Relationship | 10907 | Includes concept additions and changes as above Deprecated concepts have been excluded. |
Device Non-proprietary Therapeutic Product | 3 | no change |
Special Groupings | 1815 | 31 additional entries due to new concepts Includes concept additions and changes as above |
Coded Attributes | 7 | no change |
Since Glycopyrronium and Glycopyrrolate are synonyms, the following concept has been deprecated; 8001659 - glycopyrrolate. All existing NTPs and MPs are now associated in the relationship file with the following TM; 8001082 - glycopyrronium. The existing NTP and MP formal names with the active ingredient of glycopyrrolate have not changed in order to align with current product labels.
The following MP concepts had a change in dose form.
mp_code April Release | mp_formal_name April Release | mp_code March Release | mp_formal_name March Release |
---|---|---|---|
00443832 | DEPAKENE (valproic acid (sodium valproate) 250 mg per 5 mL syrup) BGP PHARMA ULC | 00443832 | DEPAKENE (valproic acid (sodium valproate) 250 mg per 5 mL oral solution) BGP PHARMA ULC |
02320959 | BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL syrup) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC | 02320959 | BENYLIN EXTRA STRENGTH MUCUS & PHLEGM PLUS COUGH CONTROL (dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL oral solution) MCNEIL CONSUMER HEALTHCARE DIVISION OF JOHNSON & JOHNSON INC |
Due to the MP change to MP code 02320959 as described above, the following NTP concept is no longer needed and has been deprecated;
9004569; dextromethorphan hydrobromide 15 mg per 5 mL and guaifenesin 200 mg per 5 mL and menthol 15 mg per 5 mL oral solution.
Questions and concerns and suggestions for future consideration are welcomed and should be sent by e-mail at [email protected]
Please note that to access InfoCentral, you must have an Infoway login. If you have any questions about any of our standards or products, please contact the Infodesk Desk at:
Toll Free #: 1-877-595-3417 or 416-595-3417
E-mail: [email protected]